Zhejiang Xinguang Pharmaceutical Co., Ltd.

SZSE:300519.SZ

15.16 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011
Revenue 270.4351.489320.876283.08291.262276.257310.865315.314311.478292.109267.938249.855229.617
Cost of Revenue 158.795169.232142.133126.533132.079124.48123.722109.536106.457106.994119.774134.57139.9
Gross Profit 111.605182.257178.743156.547159.183151.777187.143205.777205.021185.115148.164115.28589.717
Gross Profit Ratio 0.4130.5190.5570.5530.5470.5490.6020.6530.6580.6340.5530.4610.391
Reseach & Development Expenses 15.13415.54913.5212.0115.89717.77417.69415.10914.10911.31112.84900
General & Administrative Expenses 2.7872.7183.4552.8454.4123.343.9984.0054.2875.3215.82825.26319.415
Selling & Marketing Expenses 26.45433.73932.06132.47730.46828.69932.25336.18733.48731.75332.47524.96225.019
SG&A 29.24236.45635.51635.32234.87932.03936.25140.19237.77437.07438.30350.22544.434
Other Expenses -0.973-1.001-0.6262.303-0.359-0.1850.0146.5440.4981.0342.1276.3780.359
Operating Expenses 60.34969.1026863.04765.69664.88770.8575.67670.25666.53565.66953.1446.626
Operating Income 74.133126.605132.583112.494108.632101.043122.512132.014137.604122.08382.33260.02856.117
Operating Income Ratio 0.2740.360.4130.3970.3730.3660.3940.4190.4420.4180.3070.240.244
Total Other Income Expenses Net 21.905-1.001-0.6262.303-0.359-0.1850.0146.5260.3980.872.1185.7680.359
Income Before Tax 73.16125.604131.957114.797108.273100.857122.526138.539138.003122.95384.4565.79656.476
Income Before Tax Ratio 0.2710.3570.4110.4060.3720.3650.3940.4390.4430.4210.3150.2630.246
Income Tax Expense 8.80416.78317.67715.82114.37212.86216.36719.5819.21917.30111.9818.958.35
Net Income 64.356108.821114.2898.97693.90187.996106.159118.959118.784105.65272.46956.83846.854
Net Income Ratio 0.2380.310.3560.350.3220.3190.3410.3770.3810.3620.270.2270.204
EPS 0.40.680.710.620.590.550.660.890.990.880.610.481.56
EPS Diluted 0.40.680.710.620.590.550.660.890.990.880.610.481.56
EBITDA 66.115127.84129.381106.308104.09294.356128.434144.799144.997129.7391.42662.61740.551
EBITDA Ratio 0.2450.3640.4030.3760.3570.3420.4130.4590.4660.4440.3410.2510.177